Alkermes, Inc.
Nasdaq ALKS · Dublin 4, Ireland
Works in Neurology · Psychiatry
Alkermes, Inc. is a clinical trial sponsor based in Dublin 4, Ireland, listed as Nasdaq ALKS. It has 8 active clinical trials with 2,156 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 11 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq ALKS
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
5 approved drug applications with a product on the market.
Questions about Alkermes, Inc
Alkermes, Inc is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 2,156 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 11 trials and stopped 2 early.
Alkermes, Inc is based in Dublin 4, Ireland and is listed as Nasdaq ALKS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Alkermes, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Alkermes, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.